Zobrazeno 1 - 10
of 395
pro vyhledávání: '"MORTEN SCHOU"'
Autor:
Deewa Zahir Anjum, Anders N. Bonde, Emil Fosbol, Caroline Hartwell Garred, Gunnar Gislason, Mariam Elmegaard, Pauline Knigge, Christian Torp‐Pedersen, Charlotte Andersson, Marc A. Pfeffer, Pardeep S. Jhund, John J.V. McMurray, Mark C. Petrie, Lars Kober, Morten Schou
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3406-3415 (2024)
Abstract Aims Chronic kidney disease (CKD) is a well‐established risk factor for heart failure (HF); however, patients with an estimated glomerular filtration rate (eGFR) eGFR ≥ 30 and eGFR eGFR ≥ 30 and 72.2% for patients with eGFR eGFR ≥ 30
Externí odkaz:
https://doaj.org/article/6b8fbb6729914fe9889e775549a568c0
Autor:
Kristian Hylleberg Christensen, Roni R. Nielsen, Morten Schou, Ida Gustafsson, Anders Jorsal, Allan Flyvbjerg, Lise Tarnow, Hans Erik Bøtker, Caroline Kistorp, Mogens Johannsen, Niels Møller, Henrik Wiggers
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 837-845 (2024)
Abstract Aims In patients with chronic heart failure with reduced ejection fraction (HFrEF), myocardial ketone metabolism is increased and short‐term treatment with the ketone body 3‐hydroxy butyrate (3‐OHB) has beneficial haemodynamic effects.
Externí odkaz:
https://doaj.org/article/f7ec87d6819b4f38b4adaa973427d5db
Autor:
Louise Marqvard Sørensen, Jeppe Kofoed Petersen, Jarl Emanuel Strange, Lauge Østergaard, Jacob Eifer Møller, Morten Schou, Lars Køber, Ole de Backer, Emil Fosbøl
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 52, Iss , Pp 101423- (2024)
Background: Blood levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) has been suggested as a future guidance tool for the selection of patients for aortic valve replacement. This study aimed to examine how levels of NT-proBNP pre-transca
Externí odkaz:
https://doaj.org/article/291101eb7bed4381a08120bb97ab45ce
Autor:
Mikkel Porsborg Andersen, Christian Torp-Pedersen, Morten Schou, Gunnar Gislason, Fredrik Folke, Ruben Coronel, Talip E Eroglu, Andrim Halili, Anojhaan Arulmurugananthavadivel, Saaima Parveen, Viktoría Ellenardóttir
Publikováno v:
Open Heart, Vol 11, Iss 1 (2024)
Aim Conflicting results have been reported regarding the association between fluoroquinolones (FQs) and the risk of out-of-hospital cardiac arrest (OHCA). In particular, it has not become clear whether OHCA in FQ users is related to the inherent como
Externí odkaz:
https://doaj.org/article/2361277c78f74295853a3f23009a1ab2
Autor:
Pauline Knigge, Sørine Lundberg, Jarl E. Strange, Mariam E. Malik, Nina Nouhravesh, Andrea K. Wagner, Gunnar Gislason, Emil L. Fosbøl, Nicholas Carlson, Deewa Zahir, Charlotte Andersson, Jawad H. Butt, Pardeep Jhund, Mark C. Petrie, John J. V. McMurray, Lars Køber, Morten Schou
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Background The incidence and distribution of acute and chronic dialysis among patients with heart failure (HF), stratified by diabetes, remain uncertain. We hypothesized that with improved survival and rising comorbidities, the demand for dialysis wo
Externí odkaz:
https://doaj.org/article/b23f4c07f3714d46b62dc9fc1e7a620e
Autor:
Jesper Jensen, Mikael Kjær Poulsen, Per Warrer Petersen, Bo Gerdes, Kasper Rossing, Morten Schou
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1745-1756 (2023)
Abstract Aims Heart failure (HF) is an increasing concern worldwide. A rising HF burden is expected due to the prospected future demographic changes with aging populations. Consequently, the long‐term follow‐up and treatment will be performed inc
Externí odkaz:
https://doaj.org/article/c3a3e704bd0c40eba351bd0d0b07cc8c
Autor:
Christian Torp-Pedersen, Rikke Borg, Ditte Hansen, Lars Køber, Morten Schou, Gunnar Gislason, Theis Lange, Jonas Bjerring Olesen, Jens Dam Jensen, Iain Bressendorff, Morten Lindhardt, Mads Hornum, Erik L Grove, Marianne Rix, Anne-Lise Kamper, Christian Daugaard Peters, Jan Dominik Kampmann, Dea Haagensen Kofod, Kristine Lindhard, Frank Holden Mose, Ellen Linnea Freese Ballegaard, Finn Thomsen Nielsen, Ida Nørager Tietze, Lene Boesby, Marianne Camilla Bertelsen, Julie Maria Bøggild Brøsen, Donata Cibulskyte-Ninkovic, Jesper Moesgaard Rantanen, Alice Skovhede Nielsen, Johanne Kodal Breinholt, Peter Vilhelm Clausen, Casper Niels Furbo Bang, Nicholas Carlson
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction Atrial fibrillation is highly prevalent in patients on chronic dialysis. It is unclear whether anticoagulant therapy for stroke prevention is beneficial in these patients. Vitamin K-antagonists (VKA) remain the predominant anticoagulant
Externí odkaz:
https://doaj.org/article/bab64788782d4769b515dc81aeed052a
Autor:
Lars Køber, Morten Schou, Kasper Karmark Iversen, Dan Eik Høfsten, Finn Gustafsson, Brian Bridal Løgstrup, Olav W Nielsen, Kasper Rossing, Signe Glargaard, Jakob Hartvig Thomsen, Christian Tuxen, Christian Axel Bang, Matias Greve Lindholm, Ekim Seven, Anders Barasa, Nis Stride, Søren Vraa, Marlene Tofterup, Rasmus Vedby Rasmussen, Jens Jakob Thune
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Introduction Pleural effusion is present in half of the patients hospitalised with acute heart failure. The condition is treated with diuretics and/or therapeutic thoracentesis for larger effusions. No evidence from randomised trials or guidelines su
Externí odkaz:
https://doaj.org/article/3a0c7f501ed04e7796f4823d3efa653f
Autor:
Jeppe Kofoed Petersen, Lauge Østergaard, Nicholas Carlson, Lucas Grove Vejlstrup Bager, Jarl E. Strange, Morten Schou, Lars Køber, Emil Loldrup Fosbøl
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 1 (2024)
Background In patients undergoing transcatheter aortic valve replacement (TAVR), the impact of acute kidney injury (AKI) on the prognosis and especially on future kidney function has been sparsely examined, and data from large cohorts are warranted.
Externí odkaz:
https://doaj.org/article/fc40c124be114d9a8c2e0af441023b33
Autor:
Abbas Ali Qayyum, Mette Mouridsen, Brian Nilsson, Ida Gustafsson, Morten Schou, Olav Wendelboe Nielsen, Jens Dahlgaard Hove, Anders Bruun Mathiasen, Erik Jørgensen, Steffen Helqvist, Francis Richard Joshi, Ellen Mønsted Johansen, Bjarke Follin, Morten Juhl, Lisbeth Drozd Højgaard, Mandana Haack‐Sørensen, Annette Ekblond, Jens Kastrup
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1170-1183 (2023)
Abstract Aims Patients suffering from chronic ischaemic heart failure with reduced left ventricular ejection fraction (HFrEF) have reduced quality‐of‐life, repetitive hospital admissions, and reduced life expectancy. Allogeneic cell therapy is cu
Externí odkaz:
https://doaj.org/article/f882d6dad9da43c88abf187c99df80eb